553 related articles for article (PubMed ID: 30774269)
1. Iron and liver fibrosis: Mechanistic and clinical aspects.
Mehta KJ; Farnaud SJ; Sharp PA
World J Gastroenterol; 2019 Feb; 25(5):521-538. PubMed ID: 30774269
[TBL] [Abstract][Full Text] [Related]
2. Mouse models of hereditary hemochromatosis do not develop early liver fibrosis in response to a high fat diet.
Wagner J; Fillebeen C; Haliotis T; Charlebois E; Katsarou A; Mui J; Vali H; Pantopoulos K
PLoS One; 2019; 14(8):e0221455. PubMed ID: 31442254
[TBL] [Abstract][Full Text] [Related]
3. Liver Iron Loading in Alcohol-Associated Liver Disease.
Ali N; Ferrao K; Mehta KJ
Am J Pathol; 2023 Oct; 193(10):1427-1439. PubMed ID: 36306827
[TBL] [Abstract][Full Text] [Related]
4. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.
Ramm GA; Crawford DH; Powell LW; Walker NI; Fletcher LM; Halliday JW
J Hepatol; 1997 Mar; 26(3):584-92. PubMed ID: 9075666
[TBL] [Abstract][Full Text] [Related]
5. Iron overload in nonalcoholic steatohepatitis.
Fujita N; Takei Y
Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
[TBL] [Abstract][Full Text] [Related]
6. Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C.
Tanwar S; Rhodes F; Srivastava A; Trembling PM; Rosenberg WM
World J Gastroenterol; 2020 Jan; 26(2):109-133. PubMed ID: 31969775
[TBL] [Abstract][Full Text] [Related]
7. Iron homeostasis, hepatocellular injury, and fibrogenesis in hemochromatosis: the role of inflammation in a noninflammatory liver disease.
Ramm GA; Ruddell RG
Semin Liver Dis; 2010 Aug; 30(3):271-87. PubMed ID: 20665379
[TBL] [Abstract][Full Text] [Related]
8. Molecular pathogenesis and clinical consequences of iron overload in liver cirrhosis.
Sikorska K; Bernat A; Wroblewska A
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):461-479. PubMed ID: 27733315
[TBL] [Abstract][Full Text] [Related]
9. Role of iron in alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Salin M
Alcohol; 2003 Jun; 30(2):93-7. PubMed ID: 12957291
[TBL] [Abstract][Full Text] [Related]
10. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
11. Hepatic iron deposition in human disease and animal models.
Halliday JW; Searle J
Biometals; 1996 Apr; 9(2):205-9. PubMed ID: 8744902
[TBL] [Abstract][Full Text] [Related]
12. Iron-Induced Liver Injury: A Critical Reappraisal.
Bloomer SA; Brown KE
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31052166
[TBL] [Abstract][Full Text] [Related]
13. A high-fat diet modulates iron metabolism but does not promote liver fibrosis in hemochromatotic Hjv⁻/⁻ mice.
Padda RS; Gkouvatsos K; Guido M; Mui J; Vali H; Pantopoulos K
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G251-61. PubMed ID: 25501544
[TBL] [Abstract][Full Text] [Related]
14. Ductular reaction in hereditary hemochromatosis: the link between hepatocyte senescence and fibrosis progression.
Wood MJ; Gadd VL; Powell LW; Ramm GA; Clouston AD
Hepatology; 2014 Mar; 59(3):848-57. PubMed ID: 24037895
[TBL] [Abstract][Full Text] [Related]
15. Hepatic injury in chronic iron overload. Role of lipid peroxidation.
Bacon BR; Britton RS
Chem Biol Interact; 1989; 70(3-4):183-226. PubMed ID: 2663196
[TBL] [Abstract][Full Text] [Related]
16. Beyond hereditary hemochromatosis: new insights into the relationship between iron overload and chronic liver diseases.
Fargion S; Valenti L; Fracanzani AL
Dig Liver Dis; 2011 Feb; 43(2):89-95. PubMed ID: 20739232
[TBL] [Abstract][Full Text] [Related]
17. Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis.
Ramm GA; Ruddell RG
Semin Liver Dis; 2005 Nov; 25(4):433-49. PubMed ID: 16315137
[TBL] [Abstract][Full Text] [Related]
18. Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.
Deugnier YM; Rabot AF; Guyader D; Moirand R; Turlin B; Boucher E; Lebert P; Brissot P
Gut; 1994 Aug; 35(8):1107-11. PubMed ID: 7926915
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis and non-alcoholic fatty liver diseases.
Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
[TBL] [Abstract][Full Text] [Related]
20. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Wu J
Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
